Mike McKenzie

Quintiles Capital Solutions (Quintiles Capital) is a venture capital firm founded in 2000. The firm is headquartered in Durham, North Carolina.

Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands.

Talking Medicines Ltd. develops software for healthcare industry. It offers Medsmart, a tool that gathers real world data insight driven by patients. The company was founded by Jo Halliday, Scott Crae, and Elizabeth Fairley on April 10, 2013 and is headquartered in Glasgow, the United Kingdom.

Castor is a clinical data management company based in New York, NY. Castor provides a range of electronic solutions for clinical trials, including EDC, ePRO, eCOA, IWRS, CDMS, and decentralized trial solutions, all on a single platform. The company was founded by Derk Arts, who has been the CEO since incorporation.

Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin.

DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom.

CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom.

Part of SGS SA, Concept Life Sciences Analytical & Development Services Ltd. is a laboratory testing British company. The company is based in Cheshire, UK. The company was founded in 2014. Concept Life Sciences Analytical & Development Services was acquired by SGS SA from Spectris Plc on January 07, 2021.

Concept Life Sciences Integrated Discovery & Dev Services Ltd. designs, produces and supplies novel compounds. It offers a range of products and services to its pharmaceutical and biotechnology customers to accelerate drug discovery initiatives. The company was founded by Ray Fisher on February 9, 1989 and is headquartered in High Peak, the United Kingdom.